Scinovex
articleTop 1% cited

A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1

Transplantation · 1998 · Vol. 66(4) · pp. 507–515

Abstract

Substitution of MMF for azathioprine may reduce mortality and rejection in the first year after cardiac transplantation.

Transplantation: Methods and OutcomesRenal Transplantation Outcomes and TreatmentsPolyomavirus and related diseasesAzathioprineMedicineInternal medicineGastroenterologyHeart transplantationTransplantationRandomized controlled trialMycophenolateSurgeryDisease

MeSH terms

AgedAzathioprineDouble-Blind MethodFemaleGraft RejectionHumansImmunosuppressive AgentsMaleMiddle AgedMycophenolic AcidProspective StudiesUltrasonographySurvival RateHeart TransplantationCoronary Angiography
Citations
616
FWCI
36.86
field-weighted impact
References
34
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.